Glucagon‐like peptide‐1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52‐week, randomized, multicenter trial

Aims/Introduction:  Sulfonylurea (SU) agents are the most effective drugs at lowering blood glucose when used alone. However, their effectiveness declines after a certain period. The addition of liraglutide to existing SU therapy might reverse some of the known drawbacks of SU. Materials and Methods...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Seino, Yutaka, Rasmussen, Mads Frederik, Nishida, Tomoyuki, Kaku, Kohei
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2011
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4014968/
https://ncbi.nlm.nih.gov/pubmed/24843499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00103.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky